|
Age (years)
|
56.4
|
58.5
|
0.009
|
|
Sex (female/male)
|
56/63
|
44/37
|
0.01
|
|
BMI (kg/m2)
|
28.9
|
29.9
|
0.004
|
|
Ethnicity
| | |
0.024
|
|
White
|
58
|
49.8
| |
|
Black
|
16.9
|
19.2
| |
|
Mixed
|
18.4
|
22.4
| |
|
Asian
|
6.7
|
8.5
| |
|
Type of diabetes (1/2)
|
10.3/89.7
|
7.9/92.1
|
0.12
|
|
Diabetes duration (years)
|
13.9
|
14.4
|
0.3
|
|
HbA1c (%)
|
8.66
|
8.46
|
0.26
|
|
Smoking (yes)
|
25.2
|
25.4
|
0.94
|
|
Hypertension (yes)
|
80.1
|
84.1
|
0.063
|
|
Cardiopathy (yes)
|
26.4
|
30.9
| |
|
Dyslipidemia (yes)
|
71.1
|
75
|
0.15
|
|
Nephropathy (ClCr < 60 ml/min)
|
22.4
|
21.5
|
0.48
|
|
Retinopathy (yes)
|
42.3
|
49.1
|
0.024
|
|
Visual impairment (yes)
|
46.1
|
54.1
|
0.006
|
|
Foot at risk classification
| | |
<0.001
|
|
Foot without risk
|
53.8
|
27.1
| |
|
Neuropathic
|
19.4
|
41.4
| |
|
Ischemic
|
11.2
|
5.8
| |
|
Neuroischemic
|
15.5
|
25.7
| |
|
Previous ulceration (yes)
|
22.3
|
24.2
|
0.44
|
|
Previous amputation (yes)
|
12.6
|
13.3
|
0.7
|
|
Treatment of neuropathy (yes)
|
11.4
|
17.9
|
0.003
|
|
Region
| | |
<0.001
|
|
South/Southeast
|
64.2
|
52.1
| |
|
Northeast/Midwest
|
35.8
|
47.9
| |
